US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

PepGen Inc.

1.52

+0.190014.29%

Post-market: 1.50-0.0201-1.32%19:50 EDT

Volume:239.25K

Turnover:353.63K

Market Cap:49.69M

PE:-0.53

High:1.54

Open:1.32

Low:1.28

Close:1.33

Loading ...

Overview Company News Filings

PepGen Inc.’s CEO Makes Bold Stock Purchase!

PepGen Inc. Expands Board with New Appointments

PepGen Announces Appointment of Two New Directors to Its Board

THOMSON REUTERS

PepGen Announces Appointment of Two New Directors to its Board

PepGen Inc. Faces Clinical Trial Challenges and Competitive Pressures Leading to Sell Rating

BUZZ-U.S. STOCKS ON THE MOVE-Okta, Natgas companies, UnitedHealth

PepGen to Pause Study in Duchenne Muscular Dystrophy; Shares Down Pre-Bell

MT Newswires Live

BUZZ-PepGen slumps after pausing mid-stage study of Duchenne drug

BRIEF-Pepgen Announces Update To Phase 2 Connect2-Edo51 Study In Patients With DMD

PepGen to pause CONNECT2-EDO51 study

PepGen to Participate in Upcoming Investor Conferences

PepGen Inc - Data From 10 Mg/Kg Cohort Expected in Q3 2025

THOMSON REUTERS

PepGen Inc: Will Focus Efforts on Ongoing Connect1-Edo51 Study of Pgn-Edo51 in Dmd

THOMSON REUTERS

PepGen Inc - to Pause Phase 2 Connect2-Edo51 Study in Dmd Patients

THOMSON REUTERS

PepGen Announces Update to Phase 2 Connect2-Edo51 Study in Patients With Dmd

THOMSON REUTERS

PepGen Inc - No New Safety Issues Observed in Pgn-Edo51 Program

THOMSON REUTERS

PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD

Promising Prospects for PepGen Inc.: Buy Rating Affirmed Amid Positive DM1 Treatment Developments

PepGen Inc. Reports Positive Trial Results and Financials

Sell Rating on PepGen Inc. Amid Clinical and Regulatory Challenges

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PEPG/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PEPG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PEPG\",,,,,undefined,":{"symbol":"PEPG","market":"US","secType":"STK","nameCN":"PepGen Inc.","latestPrice":1.52,"timestamp":1745265600000,"preClose":1.33,"halted":0,"volume":239246,"hourTrading":{"tag":"盘后","latestPrice":1.4999,"preClose":1.52,"latestTime":"19:50 EDT","volume":3514,"amount":5208.6275,"timestamp":1745279442448},"delay":0,"floatShares":10471630,"shares":32692388,"eps":-2.849026,"marketStatus":"Not Yet Opened","change":0.19,"latestTime":"04-21 16:00:00 EDT","open":1.32,"high":1.54,"low":1.28,"amount":353628.38814379997,"amplitude":0.195489,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.849026,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745308800000},"marketStatusCode":0,"adr":0,"listingDate":1651809600000,"exchange":"NASDAQ","adjPreClose":1.33,"preHourTrading":{"tag":"盘前","latestPrice":1.32,"preClose":1.33,"latestTime":"09:26 EDT","volume":501,"amount":637.4269593,"timestamp":1745242002599},"postHourTrading":{"tag":"盘后","latestPrice":1.4999,"preClose":1.52,"latestTime":"19:50 EDT","volume":3514,"amount":5208.6275,"timestamp":1745279442448},"volumeRatio":1.206709,"impliedVol":0.3159,"impliedVolPercentile":0.1188},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PEPG\",,,,,undefined,":{"symbol":"PEPG","floatShares":10471630,"roa":"-41.56%","roe":"-79.26%","lyrEps":-2.849026,"volumeRatio":1.206709,"shares":32692388,"dividePrice":0,"high":1.54,"amplitude":0.195489,"preClose":1.33,"low":1.28,"week52Low":0.8801,"pbRate":"0.42","week52High":19.298,"institutionHeld":0,"latestPrice":1.52,"eps":-2.849026,"divideRate":0,"volume":239246,"delay":0,"ttmEps":-2.849026,"open":1.32,"prevYearClose":3.79,"prevWeekClose":1.33,"prevMonthClose":1.405,"prevQuarterClose":1.405,"fiveDayClose":1.13,"twentyDayClose":1.77,"sixtyDayClose":1.95},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PEPG\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526375740","title":"PepGen Inc.’s CEO Makes Bold Stock Purchase!","url":"https://stock-news.laohu8.com/highlight/detail?id=2526375740","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526375740?lang=en_us&edition=fundamental","pubTime":"2025-04-10 10:03","pubTimestamp":1744250599,"startTime":"0","endTime":"0","summary":"New insider activity at PepGen Inc. ( ($PEPG) ) has taken place on April 10, 2025. President & CEO James G McArthur has made a significant investme...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/pepgen-inc-s-ceo-makes-bold-stock-purchase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/pepgen-inc-s-ceo-makes-bold-stock-purchase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2524977799","title":"PepGen Inc. Expands Board with New Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2524977799","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524977799?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:37","pubTimestamp":1743453455,"startTime":"0","endTime":"0","summary":"PepGen Inc. ( ($PEPG) ) just unveiled an update. On March 27, 2025, PepGen Inc. announced the appointment of Mitchell Finer, Ph.D., and Lisa Wyman ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pepgen-inc-expands-board-with-new-appointments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pepgen-inc-expands-board-with-new-appointments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2524927974","title":"PepGen Announces Appointment of Two New Directors to Its Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2524927974","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524927974?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:05","pubTimestamp":1743451500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nTUA4ZDS7W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2524908956","title":"PepGen Announces Appointment of Two New Directors to its Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2524908956","media":"Business Wire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524908956?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:05","pubTimestamp":1743451500,"startTime":"0","endTime":"0","summary":"BOSTON, March 31, 2025----PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the appointments of Lisa Wyman and Mitchell H. Finer, PhD, to its Board of Directors. Ms. Wyman and Dr. Finer are industry veterans, each bringing decades of executive experience in the life sciences to the Company.\"We are thrilled to welcome Lisa and Mitch to our Board of Directors,\" said James McArthur, PhD, President and CEO of PepGen. \"Lisa’s proven ability to scale manufacturing for mid- to late-stage clinical trials and guide clinical-stage companies through global regulatory agencies, combined with Mitch’s extensive experience in driving scientific innovation and translating breakthrough research into life-changing therapies, will broaden and strengthen our Board of Directors at this crucial time for PepGen. Their guidance will be inv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pepgen-announces-appointment-two-directors-200500705.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2517918964","title":"PepGen Inc. Faces Clinical Trial Challenges and Competitive Pressures Leading to Sell Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2517918964","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517918964?lang=en_us&edition=fundamental","pubTime":"2025-03-05 19:37","pubTimestamp":1741174663,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Tazeen Ahmad from Bank of America Securities maintained a Sell rating on PepGen Inc. (PEPG – Research Report), with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/pepgen-inc-faces-clinical-trial-challenges-and-competitive-pressures-leading-to-sell-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/pepgen-inc-faces-clinical-trial-challenges-and-competitive-pressures-leading-to-sell-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PEPG"],"gpt_icon":0},{"id":"2517600360","title":"BUZZ-U.S. STOCKS ON THE MOVE-Okta, Natgas companies, UnitedHealth","url":"https://stock-news.laohu8.com/highlight/detail?id=2517600360","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517600360?lang=en_us&edition=fundamental","pubTime":"2025-03-05 02:46","pubTimestamp":1741114004,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Okta, Natgas companies, UnitedHealthEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslette","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nL3N3PN1GU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FITB","YMAB","PEP","EQT","WBA","PEPG","NVDY","UNH","JBLU","EVGO","ULCC","ILMN","NVIW.SI","WGRX","STIM","MDLZ","TNYA","NVDD","NVDS","AGH","WVE","AMLX","CNX","2NVD.UK","AAL","3NVD.UK","ATEC","SNVD.UK","NVDU","DSP","SLRN","CAPR","NEXT","UAL","OKTA","ENPH","HUT"],"gpt_icon":1},{"id":"2516639674","title":"PepGen to Pause Study in Duchenne Muscular Dystrophy; Shares Down Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2516639674","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516639674?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:09","pubTimestamp":1741097381,"startTime":"0","endTime":"0","summary":"PepGen  said Tuesday it has made a voluntary decision to temporarily  pause its CONNECT2-EDO51 phase 2 study of PGN-EDO51 in Duchenne muscular dystrophy patients until it can review results from an ongoing study.Pausing the study until PepGen is able to review results from the 10 mg/kg group in the phase 2 CONNECT1-EDO51 trial \"will allow us to gather additional safety data, assess the impact of this dose of PGN-EDO51 on dystrophin levels, and potentially improve the design of CONNECT2,\" said James McArthur, CEO of PepGen.PepGen shares were down 11% in premarket activity Tuesday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2516674856","title":"BUZZ-PepGen slumps after pausing mid-stage study of Duchenne drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2516674856","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516674856?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:04","pubTimestamp":1741097051,"startTime":"0","endTime":"0","summary":"BUZZ-PepGen slumps after pausing mid-stage study of Duchenne drug** Shares of Boston-based drug developer PepGen PEPG.O fall 9% to $2.56 premarket** Company says it will temporarily pause mid-stage study of PGN-EDO51 in patients with Duchenne muscular dystrophy  ** Says the study is paused until company can review results from patient group dosed with 10 mg/kg, which is expected during Q3** DMD is a genetic disorder causing progressive muscle weakness and degeneration** Company says no new safety issues related to PGN-EDO51 have been observed since the company's last safety update in January** PEPG has fallen 83% in the last 12 months   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nL3N3PN1AH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2516867697","title":"BRIEF-Pepgen Announces Update To Phase 2 Connect2-Edo51 Study In Patients With DMD","url":"https://stock-news.laohu8.com/highlight/detail?id=2516867697","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516867697?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:18","pubTimestamp":1741094308,"startTime":"0","endTime":"0","summary":"BRIEF-Pepgen Announces Update To Phase 2 Connect2-Edo51 Study In Patients With DMDMarch 4 (Reuters) - PepGen Inc PEPG.O:PEPGEN ANNOUNCES UPDATE TO PHASE 2 CONNECT2-EDO51 STUDY IN PATIENTS WITH DMDPEPG","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUABCFL9S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2516676863","title":"PepGen to pause CONNECT2-EDO51 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2516676863","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516676863?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:05","pubTimestamp":1741093550,"startTime":"0","endTime":"0","summary":"PepGen (PEPG) announced its voluntary decision to temporarily pause the Phase 2 CONNECT2-EDO51 study of PGN-EDO51 in patients with Duchenne muscula...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pepgen-to-pause-connect2-edo51-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pepgen-to-pause-connect2-edo51-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2516767246","title":"PepGen to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2516767246","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516767246?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:05","pubTimestamp":1741093500,"startTime":"0","endTime":"0","summary":"BOSTON, March 04, 2025----PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that management will participate in the following upcoming investor conferences:. Tuesday, March 11, 2025 at 3:00 p.m. ET, Fireside Chat. PepGen is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen’s Enhanced Delivery Oligonucleotide  platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Using these EDO peptides, we are generating a pipeline of oligonucleotide therapeutic candidates designed to target the root cause of serious diseases.For more information, please vi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pepgen-participate-upcoming-investor-conferences-130500120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2516867543","title":"PepGen Inc - Data From 10 Mg/Kg Cohort Expected in Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2516867543","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516867543?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:00","pubTimestamp":1741093206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUABCFL9S:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2516754896","title":"PepGen Inc: Will Focus Efforts on Ongoing Connect1-Edo51 Study of Pgn-Edo51 in Dmd","url":"https://stock-news.laohu8.com/highlight/detail?id=2516754896","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516754896?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:00","pubTimestamp":1741093206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUABCFL9S:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2516754366","title":"PepGen Inc - to Pause Phase 2 Connect2-Edo51 Study in Dmd Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2516754366","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516754366?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:00","pubTimestamp":1741093206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUABCFL9S:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2516675120","title":"PepGen Announces Update to Phase 2 Connect2-Edo51 Study in Patients With Dmd","url":"https://stock-news.laohu8.com/highlight/detail?id=2516675120","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516675120?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:00","pubTimestamp":1741093206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUABCFL9S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2516267548","title":"PepGen Inc - No New Safety Issues Observed in Pgn-Edo51 Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2516267548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516267548?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:00","pubTimestamp":1741093206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUABCFL9S:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PEPG","BK4139"],"gpt_icon":0},{"id":"2516675717","title":"PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD","url":"https://stock-news.laohu8.com/highlight/detail?id=2516675717","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516675717?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:00","pubTimestamp":1741093200,"startTime":"0","endTime":"0","summary":"Company will temporarily pause CONNECT2 and focus efforts on ongoing CONNECT1-EDO51 study of PGN-EDO51 in DMD, with 10 mg/kg results expected in the third quarter of 2025. BOSTON, March 04, 2025----PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced its voluntary decision to temporarily pause the Phase 2 CONNECT2-EDO51 study of PGN-EDO51 in patients with Duchenne muscular dystrophy  until the Company can review results from the 10 mg/kg cohort in the ongoing Phase 2 CONNECT1-EDO51 study. The first two cohorts of the CONNECT1 study are fully enrolled and data from the 10 mg/kg cohort are expected during the third quarter of 2025. No new safety issues related to PGN-EDO51 have been observed since the Company’s last safety update as of January 23, 2025.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pepgen-announces-phase-2-connect2-130000562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2514876585","title":"Promising Prospects for PepGen Inc.: Buy Rating Affirmed Amid Positive DM1 Treatment Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2514876585","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514876585?lang=en_us&edition=fundamental","pubTime":"2025-02-27 17:35","pubTimestamp":1740648950,"startTime":"0","endTime":"0","summary":"PepGen Inc. (PEPG – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on February 24. Analyst Joseph Schwartz...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-prospects-for-pepgen-inc-buy-rating-affirmed-amid-positive-dm1-treatment-developments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-prospects-for-pepgen-inc-buy-rating-affirmed-amid-positive-dm1-treatment-developments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PEPG"],"gpt_icon":0},{"id":"2514074377","title":"PepGen Inc. Reports Positive Trial Results and Financials","url":"https://stock-news.laohu8.com/highlight/detail?id=2514074377","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514074377?lang=en_us&edition=fundamental","pubTime":"2025-02-26 12:24","pubTimestamp":1740543866,"startTime":"0","endTime":"0","summary":"PepGen Inc. ( ($PEPG) ) has released its Q4 earnings. Here is a breakdown of the information PepGen Inc. presented to its investors. PepGen Inc. is...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pepgen-inc-reports-positive-trial-results-and-financials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pepgen-inc-reports-positive-trial-results-and-financials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PEPG"],"gpt_icon":0},{"id":"2514043066","title":"Sell Rating on PepGen Inc. Amid Clinical and Regulatory Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2514043066","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514043066?lang=en_us&edition=fundamental","pubTime":"2025-02-25 17:55","pubTimestamp":1740477319,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Tazeen Ahmad reiterated a Sell rating on PepGen Inc. (PEPG – Research Report) yesterday and set a price target o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sell-rating-on-pepgen-inc-amid-clinical-and-regulatory-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sell-rating-on-pepgen-inc-amid-clinical-and-regulatory-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PEPG"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":79,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PEPG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-24","symbol":"PEPG","fiscalQuarterEnding":"2024/12","expectedEps":-0.81,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740373200000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2024-11-07","symbol":"PEPG","fiscalQuarterEnding":"2024/09","expectedEps":-0.87,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.66},{"market":"US","date":"2024-03-06","symbol":"PEPG","fiscalQuarterEnding":"2023/12","expectedEps":-1.01,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709701200000,"reportTimeType":"post","actualEps":-0.82}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PEPG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PEPG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.2,"hold":0,"sell":0.2,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2,"analysts":5,"updateTime":1734580800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PEPG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PEPG","date":"2025-04-17","current":-0.44689,"percent":0.990223,"low":-10.580456,"twenty":-6.043655,"median":-4.305274,"eighty":-1.867769,"high":-0.363325,"avg":-4.075649,"sd":2.223783,"marketCap":40211637},"quantilePoints":[{"date":"2022-05-06","current":-10.580456,"twenty":-10.288242,"median":-9.84992,"eighty":-9.367212,"marketCap":288645421},{"date":"2022-05-13","current":-9.628297,"twenty":-9.817087,"median":-9.763734,"eighty":-9.34265,"marketCap":262669573},{"date":"2022-05-20","current":-9.226092,"twenty":-9.772763,"median":-9.628297,"eighty":-9.232659,"marketCap":251697016},{"date":"2022-05-27","current":-8.930594,"twenty":-9.767838,"median":-9.336904,"eighty":-8.669571,"marketCap":243635546},{"date":"2022-06-03","current":-8.684346,"twenty":-9.766196,"median":-9.205571,"eighty":-8.733596,"marketCap":236917654},{"date":"2022-06-10","current":-9.160426,"twenty":-9.733363,"median":-9.152218,"eighty":-8.728671,"marketCap":249905578},{"date":"2022-06-17","current":-6.915214,"twenty":-9.615164,"median":-9.094708,"eighty":-8.515256,"marketCap":268939605},{"date":"2022-06-24","current":-6.759752,"twenty":-9.562631,"median":-9.000364,"eighty":-7.559814,"marketCap":262893503},{"date":"2022-07-01","current":-5.878796,"twenty":-9.431299,"median":-8.90597,"eighty":-6.828846,"marketCap":228632254},{"date":"2022-07-08","current":-6.892183,"twenty":-9.280267,"median":-8.643305,"eighty":-6.816179,"marketCap":268043886},{"date":"2022-07-15","current":-5.395134,"twenty":-9.229375,"median":-8.544806,"eighty":-6.734417,"marketCap":209822157},{"date":"2022-07-22","current":-6.788541,"twenty":-9.193259,"median":-8.183642,"eighty":-6.38549,"marketCap":264013151},{"date":"2022-07-29","current":-6.448826,"twenty":-9.165351,"median":-7.364369,"eighty":-6.443068,"marketCap":250801297},{"date":"2022-08-05","current":-6.489131,"twenty":-9.15386,"median":-7.047646,"eighty":-6.405066,"marketCap":252368805},{"date":"2022-08-12","current":-4.845367,"twenty":-9.152218,"median":-6.946883,"eighty":-6.325607,"marketCap":246227027},{"date":"2022-08-19","current":-4.706266,"twenty":-9.145651,"median":-6.897941,"eighty":-6.120627,"marketCap":239158309},{"date":"2022-08-26","current":-4.581074,"twenty":-9.065127,"median":-6.854757,"eighty":-5.91104,"marketCap":232796462},{"date":"2022-09-02","current":-4.534707,"twenty":-9.038923,"median":-6.811573,"eighty":-5.653087,"marketCap":230440223},{"date":"2022-09-09","current":-4.590348,"twenty":-8.992977,"median":-6.794299,"eighty":-4.938101,"marketCap":233267710},{"date":"2022-09-16","current":-2.610471,"twenty":-8.943727,"median":-6.719447,"eighty":-4.823111,"marketCap":132656283},{"date":"2022-09-23","current":-2.309084,"twenty":-8.91582,"median":-6.615805,"eighty":-4.590348,"marketCap":117340727},{"date":"2022-09-30","current":-4.210137,"twenty":-8.772996,"median":-6.468979,"eighty":-4.540271,"marketCap":213946546},{"date":"2022-10-07","current":-5.559421,"twenty":-8.659721,"median":-6.420037,"eighty":-4.540271,"marketCap":282513116},{"date":"2022-10-14","current":-5.100387,"twenty":-8.62853,"median":-6.296242,"eighty":-4.566237,"marketCap":259186345},{"date":"2022-10-21","current":-4.349239,"twenty":-8.603905,"median":-6.143658,"eighty":-4.540271,"marketCap":221015265},{"date":"2022-10-28","current":-5.012289,"twenty":-8.534956,"median":-6.077443,"eighty":-4.532853,"marketCap":254709489},{"date":"2022-11-04","current":-4.984469,"twenty":-8.470931,"median":-5.988196,"eighty":-4.540271,"marketCap":253295746},{"date":"2022-11-11","current":-5.134023,"twenty":-8.291991,"median":-5.898949,"eighty":-4.552327,"marketCap":314777227},{"date":"2022-11-18","current":-6.051364,"twenty":-7.809345,"median":-5.878796,"eighty":-4.571801,"marketCap":371021206},{"date":"2022-11-25","current":-5.746868,"twenty":-7.490864,"median":-5.870208,"eighty":-4.584784,"marketCap":352351986},{"date":"2022-12-02","current":-5.758431,"twenty":-7.368983,"median":-5.771921,"eighty":-4.590348,"marketCap":353060944},{"date":"2022-12-09","current":-5.238091,"twenty":-7.334388,"median":-5.758431,"eighty":-4.61075,"marketCap":321157847},{"date":"2022-12-16","current":-5.477062,"twenty":-7.213473,"median":-5.732221,"eighty":-4.667318,"marketCap":335809640},{"date":"2022-12-23","current":-5.789266,"twenty":-7.047646,"median":-5.746868,"eighty":-4.706266,"marketCap":354951498},{"date":"2022-12-30","current":-5.153295,"twenty":-7.031524,"median":-5.693886,"eighty":-4.71183,"marketCap":315958823},{"date":"2023-01-06","current":-5.804684,"twenty":-6.967035,"median":-5.693886,"eighty":-4.734086,"marketCap":355896775},{"date":"2023-01-13","current":-6.166995,"twenty":-6.92673,"median":-5.693397,"eighty":-4.789727,"marketCap":378110784},{"date":"2023-01-20","current":-6.664209,"twenty":-6.917517,"median":-5.707168,"eighty":-4.808273,"marketCap":408595965},{"date":"2023-01-27","current":-6.213247,"twenty":-6.901396,"median":-5.75788,"eighty":-4.816954,"marketCap":380946614},{"date":"2023-02-03","current":-5.928024,"twenty":-6.893335,"median":-5.769995,"eighty":-4.836178,"marketCap":363458991},{"date":"2023-02-10","current":-6.587121,"twenty":-6.88297,"median":-5.781558,"eighty":-4.84444,"marketCap":403869581},{"date":"2023-02-17","current":-6.556286,"twenty":-6.83921,"median":-5.804684,"eighty":-4.849077,"marketCap":401979027},{"date":"2023-02-24","current":-6.47149,"twenty":-6.824881,"median":-5.862986,"eighty":-4.852786,"marketCap":396780003},{"date":"2023-03-03","current":-6.109179,"twenty":-6.819293,"median":-5.878796,"eighty":-4.862987,"marketCap":374565995},{"date":"2023-03-10","current":-5.538732,"twenty":-6.813876,"median":-5.902363,"eighty":-4.871333,"marketCap":339590747},{"date":"2023-03-17","current":-6.822238,"twenty":-6.813876,"median":-5.878796,"eighty":-4.88988,"marketCap":418285054},{"date":"2023-03-24","current":-5.241352,"twenty":-6.804663,"median":-5.882211,"eighty":-4.914918,"marketCap":362198413},{"date":"2023-03-31","current":-4.208913,"twenty":-6.796602,"median":-5.870208,"eighty":-4.852786,"marketCap":290852698},{"date":"2023-04-06","current":-3.957686,"twenty":-6.791996,"median":-5.809194,"eighty":-4.827071,"marketCap":273491907},{"date":"2023-04-14","current":-3.548151,"twenty":-6.78653,"median":-5.796975,"eighty":-4.717394,"marketCap":245191440},{"date":"2023-04-21","current":-4.322481,"twenty":-6.774009,"median":-5.777703,"eighty":-4.590348,"marketCap":298700726},{"date":"2023-04-28","current":-5.062396,"twenty":-6.727508,"median":-5.762285,"eighty":-4.590348,"marketCap":349831822},{"date":"2023-05-05","current":-5.059038,"twenty":-6.673168,"median":-5.746868,"eighty":-4.594705,"marketCap":349599765},{"date":"2023-05-12","current":-5.041307,"twenty":-6.664209,"median":-5.695324,"eighty":-4.617285,"marketCap":338659909},{"date":"2023-05-19","current":-5.292665,"twenty":-6.651757,"median":-5.689053,"eighty":-4.651462,"marketCap":355545340},{"date":"2023-05-26","current":-5.027146,"twenty":-6.627029,"median":-5.6428,"eighty":-4.682483,"marketCap":337708617},{"date":"2023-06-02","current":-5.22186,"twenty":-6.617526,"median":-5.615819,"eighty":-4.706266,"marketCap":350788880},{"date":"2023-06-09","current":-5.80246,"twenty":-6.613923,"median":-5.619674,"eighty":-4.709351,"marketCap":389791847},{"date":"2023-06-16","current":-4.570455,"twenty":-6.602539,"median":-5.600402,"eighty":-4.646407,"marketCap":307029454},{"date":"2023-06-23","current":-3.402174,"twenty":-6.587121,"median":-5.577654,"eighty":-4.590348,"marketCap":228547874},{"date":"2023-06-30","current":-3.455278,"twenty":-6.584038,"median":-5.56064,"eighty":-4.555109,"marketCap":232115218},{"date":"2023-07-07","current":-2.793252,"twenty":-6.569391,"median":-5.550856,"eighty":-4.526361,"marketCap":187642323},{"date":"2023-07-14","current":-2.956104,"twenty":-6.557828,"median":-5.538732,"eighty":-4.44661,"marketCap":198582179},{"date":"2023-07-21","current":-2.821574,"twenty":-6.553974,"median":-5.502116,"eighty":-4.393239,"marketCap":189544907},{"date":"2023-07-28","current":-2.017939,"twenty":-6.547807,"median":-5.477062,"eighty":-4.337232,"marketCap":135559092},{"date":"2023-08-04","current":-2.017939,"twenty":-6.54246,"median":-5.426956,"eighty":-4.319075,"marketCap":135559092},{"date":"2023-08-11","current":-1.819033,"twenty":-6.538589,"median":-5.413033,"eighty":-4.237584,"marketCap":126211799},{"date":"2023-08-18","current":-2.309829,"twenty":-6.537014,"median":-5.39612,"eighty":-4.161181,"marketCap":160265171},{"date":"2023-08-25","current":-1.841342,"twenty":-6.508284,"median":-5.365285,"eighty":-3.959751,"marketCap":127759679},{"date":"2023-09-01","current":-2.162247,"twenty":-6.487797,"median":-5.32819,"eighty":-3.925336,"marketCap":150025346},{"date":"2023-09-08","current":-2.165679,"twenty":-6.480741,"median":-5.297975,"eighty":-3.659632,"marketCap":150263481},{"date":"2023-09-15","current":-2.097036,"twenty":-6.468406,"median":-5.292052,"eighty":-3.522166,"marketCap":145500772},{"date":"2023-09-22","current":-1.887676,"twenty":-6.457799,"median":-5.24042,"eighty":-3.35802,"marketCap":130974508},{"date":"2023-09-29","current":-1.743526,"twenty":-6.448826,"median":-5.22186,"eighty":-3.217961,"marketCap":120972818},{"date":"2023-10-06","current":-1.678316,"twenty":-6.448641,"median":-5.175203,"eighty":-3.007083,"marketCap":116448244},{"date":"2023-10-13","current":-1.935726,"twenty":-6.437033,"median":-5.153295,"eighty":-2.877511,"marketCap":134308405},{"date":"2023-10-20","current":-1.87738,"twenty":-6.41595,"median":-5.138035,"eighty":-2.738733,"marketCap":130260102},{"date":"2023-10-27","current":-1.832762,"twenty":-6.411863,"median":-5.137386,"eighty":-2.672884,"marketCap":127164340},{"date":"2023-11-03","current":-1.760687,"twenty":-6.391319,"median":-5.132844,"eighty":-2.525739,"marketCap":122163496},{"date":"2023-11-10","current":-1.30856,"twenty":-6.383611,"median":-5.099169,"eighty":-2.414802,"marketCap":96921136},{"date":"2023-11-17","current":-1.337497,"twenty":-6.379756,"median":-5.08379,"eighty":-2.30968,"marketCap":99064355},{"date":"2023-11-24","current":-1.440381,"twenty":-6.365109,"median":-5.06793,"eighty":-2.272918,"marketCap":106684690},{"date":"2023-12-01","current":-1.575417,"twenty":-6.353547,"median":-5.060717,"eighty":-2.182362,"marketCap":116686380},{"date":"2023-12-08","current":-2.038396,"twenty":-6.347912,"median":-5.041307,"eighty":-2.155383,"marketCap":150977887},{"date":"2023-12-15","current":-2.279531,"twenty":-6.330776,"median":-5.005334,"eighty":-2.155383,"marketCap":168838048},{"date":"2023-12-22","current":-2.173432,"twenty":-6.314232,"median":-4.961285,"eighty":-2.139706,"marketCap":160979577},{"date":"2023-12-27","current":-2.276316,"twenty":-6.309607,"median":-4.947375,"eighty":-2.145086,"marketCap":168599912},{"date":"2024-01-05","current":-2.517451,"twenty":-6.309607,"median":-4.917622,"eighty":-2.145086,"marketCap":186460073},{"date":"2024-01-12","current":-2.237735,"twenty":-6.293418,"median":-4.901008,"eighty":-2.152448,"marketCap":165742287},{"date":"2024-01-19","current":-2.176647,"twenty":-6.279542,"median":-4.868551,"eighty":-2.149994,"marketCap":161217713},{"date":"2024-01-26","current":-2.228089,"twenty":-6.26387,"median":-4.847686,"eighty":-2.159312,"marketCap":165027880},{"date":"2024-02-02","current":-3.983553,"twenty":-6.236762,"median":-4.817965,"eighty":-2.162863,"marketCap":295049847},{"date":"2024-02-09","current":-6.385761,"twenty":-6.236762,"median":-4.815437,"eighty":-2.164543,"marketCap":472974124},{"date":"2024-02-16","current":-5.971046,"twenty":-6.217872,"median":-4.845367,"eighty":-2.168425,"marketCap":442257448},{"date":"2024-02-23","current":-5.903337,"twenty":-6.211356,"median":-4.854641,"eighty":-2.172721,"marketCap":437242480},{"date":"2024-03-01","current":-7.172872,"twenty":-6.242031,"median":-4.887098,"eighty":-2.174075,"marketCap":531273121},{"date":"2024-03-08","current":-5.652729,"twenty":-6.270849,"median":-4.911053,"eighty":-2.177199,"marketCap":444451496},{"date":"2024-03-15","current":-5.723947,"twenty":-6.25312,"median":-4.95433,"eighty":-2.180142,"marketCap":450051025},{"date":"2024-03-22","current":-6.086065,"twenty":-6.25312,"median":-4.998379,"eighty":-2.183328,"marketCap":478522981},{"date":"2024-03-28","current":-5.798016,"twenty":-6.2473,"median":-5.027146,"eighty":-2.184331,"marketCap":455874834},{"date":"2024-04-05","current":-4.76927,"twenty":-6.220956,"median":-5.034226,"eighty":-2.189508,"marketCap":374988597},{"date":"2024-04-12","current":-5.230148,"twenty":-6.213247,"median":-5.027146,"eighty":-2.189704,"marketCap":411225631},{"date":"2024-04-19","current":-4.879466,"twenty":-6.203794,"median":-5.029888,"eighty":-2.199153,"marketCap":383652857},{"date":"2024-04-26","current":-4.819734,"twenty":-6.166995,"median":-4.998379,"eighty":-2.205583,"marketCap":378956389},{"date":"2024-05-03","current":-5.969241,"twenty":-6.166995,"median":-5.005334,"eighty":-2.208798,"marketCap":469337548},{"date":"2024-05-10","current":-5.495492,"twenty":-6.149416,"median":-5.032629,"eighty":-2.208798,"marketCap":432088536},{"date":"2024-05-17","current":-5.508665,"twenty":-6.148781,"median":-5.053766,"eighty":-2.212013,"marketCap":442494520},{"date":"2024-05-24","current":-5.746768,"twenty":-6.143658,"median":-5.062396,"eighty":-2.217161,"marketCap":461620657},{"date":"2024-05-31","current":-6.598291,"twenty":-6.148908,"median":-5.06793,"eighty":-2.225903,"marketCap":530020909},{"date":"2024-06-07","current":-6.99782,"twenty":-6.205685,"median":-5.084957,"eighty":-2.235806,"marketCap":562113918},{"date":"2024-06-14","current":-7.05432,"twenty":-6.25021,"median":-5.092261,"eighty":-2.239664,"marketCap":566652323},{"date":"2024-06-21","current":-6.779895,"twenty":-6.298815,"median":-5.107245,"eighty":-2.245948,"marketCap":544608640},{"date":"2024-06-28","current":-6.642683,"twenty":-6.31192,"median":-5.123473,"eighty":-2.250945,"marketCap":533586799},{"date":"2024-07-05","current":-6.731467,"twenty":-6.352619,"median":-5.135459,"eighty":-2.255593,"marketCap":540718579},{"date":"2024-07-12","current":-6.981678,"twenty":-6.380527,"median":-5.138193,"eighty":-2.258955,"marketCap":560817231},{"date":"2024-07-15","current":-6.796038,"twenty":-6.383424,"median":-5.139314,"eighty":-2.259598,"marketCap":545905328},{"date":"2024-08-02","current":-4.063901,"twenty":-6.38284,"median":-5.138193,"eighty":-2.260241,"marketCap":326441012},{"date":"2024-08-09","current":-3.2831,"twenty":-6.378985,"median":-5.135459,"eighty":-2.276316,"marketCap":292655523},{"date":"2024-08-16","current":-3.316004,"twenty":-6.360187,"median":-5.114102,"eighty":-2.279531,"marketCap":295588597},{"date":"2024-08-23","current":-3.549989,"twenty":-6.355859,"median":-5.092261,"eighty":-2.279531,"marketCap":316446006},{"date":"2024-08-30","current":-3.381812,"twenty":-6.35354,"median":-5.08379,"eighty":-2.285901,"marketCap":301454743},{"date":"2024-09-06","current":-3.239228,"twenty":-6.352312,"median":-5.06793,"eighty":-2.296807,"marketCap":288744759},{"date":"2024-09-13","current":-3.308692,"twenty":-6.346548,"median":-5.060717,"eighty":-2.307174,"marketCap":294936803},{"date":"2024-09-20","current":-3.418372,"twenty":-6.325973,"median":-5.048713,"eighty":-2.30968,"marketCap":304713713},{"date":"2024-09-27","current":-3.177075,"twenty":-6.31192,"median":-5.029888,"eighty":-2.311389,"marketCap":283204510},{"date":"2024-10-04","current":-3.290412,"twenty":-6.309607,"median":-4.998379,"eighty":-2.327135,"marketCap":293307318},{"date":"2024-10-11","current":-3.162451,"twenty":-6.288022,"median":-4.972877,"eighty":-2.336118,"marketCap":281900922},{"date":"2024-10-18","current":-3.242884,"twenty":-6.276459,"median":-4.924191,"eighty":-2.340714,"marketCap":289070656},{"date":"2024-10-25","current":-3.008899,"twenty":-6.258643,"median":-4.907611,"eighty":-2.384529,"marketCap":268213247},{"date":"2024-10-31","current":-2.584801,"twenty":-6.25021,"median":-4.898921,"eighty":-2.404766,"marketCap":230409193},{"date":"2024-11-08","current":-2.103309,"twenty":-6.231494,"median":-4.879466,"eighty":-2.384804,"marketCap":183480022},{"date":"2024-11-15","current":-1.677727,"twenty":-6.216331,"median":-4.870869,"eighty":-2.323296,"marketCap":146354859},{"date":"2024-11-22","current":-1.614205,"twenty":-6.207575,"median":-4.850004,"eighty":-2.29408,"marketCap":140813583},{"date":"2024-11-29","current":-1.886976,"twenty":-6.189074,"median":-4.840731,"eighty":-2.277602,"marketCap":164608471},{"date":"2024-12-06","current":-2.103698,"twenty":-6.166995,"median":-4.81885,"eighty":-2.254876,"marketCap":183513999},{"date":"2024-12-13","current":-1.928079,"twenty":-6.159963,"median":-4.811645,"eighty":-2.233539,"marketCap":168194002},{"date":"2024-12-20","current":-1.528264,"twenty":-6.149162,"median":-4.753308,"eighty":-2.210084,"marketCap":133316564},{"date":"2024-12-27","current":-1.599259,"twenty":-6.147756,"median":-4.727888,"eighty":-2.200439,"marketCap":139509754},{"date":"2025-01-03","current":-1.408693,"twenty":-6.143658,"median":-4.706266,"eighty":-2.184331,"marketCap":122885928},{"date":"2025-01-10","current":-1.289122,"twenty":-6.143178,"median":-4.693198,"eighty":-2.176004,"marketCap":112455292},{"date":"2025-01-17","current":-0.904254,"twenty":-6.136968,"median":-4.641352,"eighty":-2.163478,"marketCap":78881683},{"date":"2025-01-24","current":-0.728634,"twenty":-6.130009,"median":-4.590348,"eighty":-2.145086,"marketCap":63561687},{"date":"2025-01-31","current":-0.538068,"twenty":-6.121945,"median":-4.575765,"eighty":-2.127223,"marketCap":46937861},{"date":"2025-02-07","current":-0.515649,"twenty":-6.113101,"median":-4.543981,"eighty":-2.103542,"marketCap":44982117},{"date":"2025-02-14","current":-0.452127,"twenty":-6.104554,"median":-4.525434,"eighty":-2.087226,"marketCap":39440841},{"date":"2025-02-21","current":-0.538068,"twenty":-6.09992,"median":-4.492102,"eighty":-2.061071,"marketCap":46937861},{"date":"2025-02-28","current":-0.882881,"twenty":-6.092983,"median":-4.472991,"eighty":-2.017939,"marketCap":79442502},{"date":"2025-03-07","current":-0.879248,"twenty":-6.084519,"median":-4.411834,"eighty":-1.989801,"marketCap":79115578},{"date":"2025-03-14","current":-0.817482,"twenty":-6.072235,"median":-4.394752,"eighty":-1.946683,"marketCap":73557873},{"date":"2025-03-21","current":-0.684868,"twenty":-6.05492,"median":-4.34833,"eighty":-1.929079,"marketCap":61625151},{"date":"2025-03-28","current":-0.584954,"twenty":-6.050431,"median":-4.33982,"eighty":-1.913074,"marketCap":52634744},{"date":"2025-04-04","current":-0.455973,"twenty":-6.048422,"median":-4.324202,"eighty":-1.891794,"marketCap":41028946},{"date":"2025-04-11","current":-0.425091,"twenty":-6.045967,"median":-4.31904,"eighty":-1.87532,"marketCap":38250093},{"date":"2025-04-17","current":-0.44689,"twenty":-6.043655,"median":-4.305274,"eighty":-1.867769,"marketCap":40211637}],"updateTime":1745274725908}}}